Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma

The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the bi...

Full description

Bibliographic Details
Main Authors: Khin-Than Win, Yen-Chuan Hsieh, Hung-Chang Wu, Shih-Sung Chuang
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/14/6/640
_version_ 1827306566738509824
author Khin-Than Win
Yen-Chuan Hsieh
Hung-Chang Wu
Shih-Sung Chuang
author_facet Khin-Than Win
Yen-Chuan Hsieh
Hung-Chang Wu
Shih-Sung Chuang
author_sort Khin-Than Win
collection DOAJ
description The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation.
first_indexed 2024-04-24T18:23:38Z
format Article
id doaj.art-8afc131a772c4a29a076babc40b54b39
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-04-24T18:23:38Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-8afc131a772c4a29a076babc40b54b392024-03-27T13:33:24ZengMDPI AGDiagnostics2075-44182024-03-0114664010.3390/diagnostics14060640Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone LymphomaKhin-Than Win0Yen-Chuan Hsieh1Hung-Chang Wu2Shih-Sung Chuang3Department of Pathology, Chi-Mei Medical Center, Tainan 710, TaiwanDepartment of Clinical Pathology, Chi-Mei Medical Center, Tainan 710, TaiwanDivision of Hemato-Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan 710, TaiwanDepartment of Pathology, Chi-Mei Medical Center, Tainan 710, TaiwanThe diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation.https://www.mdpi.com/2075-4418/14/6/640CD5CD10marginal zone lymphomaphenotypic aberrancysplenic marginal zone lymphomavillous lymphocyte
spellingShingle Khin-Than Win
Yen-Chuan Hsieh
Hung-Chang Wu
Shih-Sung Chuang
Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
Diagnostics
CD5
CD10
marginal zone lymphoma
phenotypic aberrancy
splenic marginal zone lymphoma
villous lymphocyte
title Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
title_full Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
title_fullStr Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
title_full_unstemmed Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
title_short Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
title_sort nodal low grade b cell lymphoma co expressing cd5 and cd10 but not cd23 irta1 or cyclin d1 the diagnostic challenge of a splenic marginal zone lymphoma
topic CD5
CD10
marginal zone lymphoma
phenotypic aberrancy
splenic marginal zone lymphoma
villous lymphocyte
url https://www.mdpi.com/2075-4418/14/6/640
work_keys_str_mv AT khinthanwin nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma
AT yenchuanhsieh nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma
AT hungchangwu nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma
AT shihsungchuang nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma